Viewing on a PDA? Click here to read this email.
Medical Progress Today
mpt home | sign up

Volume 8, Number 5
February 3, 2011


PRINTER FRIENDLY

In the Spotlight

The Whooping Cough's Unnecessary Return
Vaccination fears allow a once-vanquished killer to stalk California’s children

Paul Howard, James R. Copland, City Journal, 2-3-11

Vaccines, which save millions of lives every year, are one of the most successful public-health interventions in the history of modern medicine. Among the diseases that they prevent is the whooping cough. Why, then, is that sickness making a scary comeback in California, which is currently weathering its largest whooping-cough epidemic since 1947, with over 7,800 cases and 10 deaths in 2010? Mainly because more and more parents, worried about the vaccine's supposed side effects, are choosing to delay vaccinating their children—or not to do it at all. This public-health calamity, moreover, comes at a time when the Supreme Court is considering a lawsuit against whooping-cough vaccine manufacturer Wyeth; if successful, the suit would make epidemics much more likely and undermine public confidence in vaccines even further.
Continue reading . . .


News

· Medical Device Recalls and the FDA Approval Process, Zuckerman, D. M., Brown, P., Nissen, S. E., Archives of Internal Medicine, 6-14-11
· Patent Reform Gets Key Support in House, Julian Pecquet, The Hill, 6-14-11
· $4.3 Billion Pledged at Vaccine Fund-Raiser, Donald G. McNeil Jr., New York Times, 6-13-2011
· Physicians Leaving Practices for health System Employment, Karen Cheung, FierceHealthcare, 6-13-11

More Headlines >>


Commentary

· Marco Rubio takes on 'Medi-scare' Marc A. Thiessen, Washington Post, 6-13-11
· 'Vouchercare' Is the Right Name for Medicare Laurence Kotlikoff, Bloomberg, 6-15-11
· Built To Fail: Health Insurance Exchanges Under The Affordable Care Act
· Can Exchanges Help Consumers Get Good Value Insurance? Depends On Where You Live Sabrina Corlette, Kaiser Health News, 6-15-11
· The ObamaCare Bad News Continues Karl Rove, Wall Street Journal, 6-16-11
· ObamaCare's Economic Flaws Doug Holtz-Eakin, Investor's Business Daily, 6-8-11

More Commentary >>


Research

· Why States Are So Miffed about Medicaid — Economics, Politics, and the "Woodwork Effect", Benjamin D. Sommers et al., New England Journal of Medicine, 6-15-11
· Auditing Access to Specialty Care for Children with Public Insurance, Joanna bisgaier et al., New England Journal of Medicine, 6-16-11
· Moving Beyond Fee-For-Service: The Case for Managed Care in Medicaid, Michael Ramlet and Carey Lafferty, American Action Forum, 6-14-11
· The New Gold Rush: Prospectors are Hoping to Mine Opportunities in the Healthcare Industry, Health Research Institute, PricewatershouseCoopers, 6-14-11
· Active Purchasing for Health Insurance Exchanges: An Analysis of Options, Sabrina Corlette and JoAnn Volk, RWJF, 6-14-11

More Research>>



Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.

For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at phoward@manhattan-institute.org, or via telephone at 212.599.7000.

Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at communications@manhattan-institute.org, or via telephone at 212.599.7000.

If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line.

SPOTLIGHT

The Whooping Cough's Unnecessary Return

INNOVATIVE IDEAS:
Podcast Series


Tevi Troy is a Senior Fellow at the Hudson Institute, a Senior Fellow at the Potomac Institute, and a writer and consultant on health care and domestic policy.

Click here to listen to the podcast

"You just don’t want to have a government entity [National Institutes of Health] doing this kind of creation of applied research because they’re not that good at it. The reason they’re not that good at it is because pharmaceutical companies understand the market, understand what can sell, understand the process of how to get things through the FDA. . .and they’re just better at it than a government entity which doesn’t have the same type of incentive structure that can lead people to make the smart decisions that can make a compound that can actually work."
Tevi Troy

Center for Medical Progress 
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org